Human natural killer cell activating receptors

Molecular Immunology

Volumn 37, Issue 17, 2000, Pages 1015-1024

  Biassoni, Roberto ^a,d   Cantoni, Claudia ^b,c   Falco, Michela ^b,c   Pende, Daniela ^a   Millo, Romano ^b   Moretta, Lorenzo ^b,c   Bottino, Cristina ^a   Moretta, Alessandro ^b  

^a CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d Tel: +39 010 5737221   (Italy)

Author keywords

HLA; Natural killer; Receptors

Indexed keywords

CELL RECEPTOR; HLA ANTIGEN CLASS 1; LECTIN; LIGAND; MEMBRANE PROTEIN;

ALLELE; CELL PROTECTION; CELL SURFACE; CHEMICAL STRUCTURE; CLONE; CYTOLYSIS; DOWN REGULATION; HLA SYSTEM; HUMAN; MOLECULAR DYNAMICS; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; TARGET CELL; TUMOR CELL LINE;

EID: 0034861502     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00018-9     Document Type: Review

References (99)

1. Activation of NK cells and T cells by NKG2D a receptor for stress-inducible MICA
2. Divergent and convergent evolution of NK-cell receptors
3. Defective NK cell activation in X-linked lymphoproliferative disease
4. The HLA.C specific 'activatory' and 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions
5. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for Cw4 molecules
6. The murine homologue of the human NKp46 a triggering receptor involved in the induction of natural cytotoxicity
7. Human natural killer cell receptors and coreceptors
8. Activation and function of natural killer cell responses during viral infections
9. Molecular cloning of a novel natural killer cell receptor homologous to mouse 2B4
10. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 kDa sheep erythrocyte receptor
11. Inhibitory pathways triggered by ITIM-containing receptors
12. Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
13. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation
14. Identification of natural p50.2/KIR2DS mutants unable to transduce activating signals
15. The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering
16. Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: Evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells
17. Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes
18. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
19. NKG2A complexed with CD94 defines a novel inhibitory NK cell receptor
20. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48
21. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor
22. Tyrosine phosphorilation of a human killer inhibitory receptor recruits protein phosphatase 1C
23. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex
24. The activating form of CD94 receptor complex. CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene
25. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily
26. The CD94 and NKG2-A C-type lectins covalently assamble to form a NK cell inhibitory receptor for HLA class I molecules
27. Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily
28. KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties
29. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
30. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
31. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
32. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes
33. A human killer inhibitory receptor specific for HLA-A
34. Identification of the rat homologue of the human NKp46 triggering receptor
35. Phenotypic and functional characterization of recombinant interleukin-2 (rIL-2)-induced killer cells: Analysis at the population and the clonal level
36. MHC molecules in normal and neoplastic cells
37. Implications for immunosurveillance of altered HLA-class I phenotypes in human tumours
38. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2-activated autologous human peripheral blood lymphocytes
39. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium
40. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB
41. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells
42. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C
43. Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48
44. NK cell receptors
45. Association of DAP12 with activating CD94/NKG2C NK cell receptors
46. Immunoreceptor DAP12 bearing a tyrosine-based activation motifs is involved in activating NK cells
47. Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells
48. Identification of the 2B4 molecule as a counter-receptor for CD48
49. Human natural killer cell receptors involved in MHC class I recognition are disulphide-linked heterodimers of CD94 and NKG2 subunits
50. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
51. Regulation of immune responses through inhibitory receptors
52. Structure and function of the CD94 C-type lectin receptor complex involved in the recognition of HLA class I molecules
53. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity
54. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
55. Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery
56. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA.C molecules in human natural killer cells
57. Receptors for HLA-class I molecules in human natural killer cells
58. Major histocompatibility complex class I-specifc receptors on human natural killer and T lymphocytes
59. Natural cytotoxicity receptors that trigger human NK-mediated cytolysis
60. Human NK-cell receptors
61. Activating receptors and coreceptors involved in the natural cytotoxicity
62. Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain
63. Activating interactions in human NK cell recognition: The role of 2B4-CD48
64. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity
65. Genes in a 220-kb region spanning the TNF cluster in human MHC
66. A new member of the Ig superfamily and a V-ATPase G subunit are among the predicted products of novel genes close to the TNF locus in the human MHC
67. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
68. Human and mouse natural killer cell inhibitory receptors recruit the PTP1C and PTP1D protein tyrosine phosphatases
69. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells
70. Family of disulphide-linked dimers containing the zeta and eta chains of the T-cell receptor and the gammachain of Fc receptors
71. X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of NK cells to kill EBV-infected cells
72. The natural killer receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140 kDa disulphide-linked dimer
73. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
74. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
75. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
76. Viral strategies of immune evasion
77. Crystal structure of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition
78. Human KLRF1, a novel member of the killer cell lectin-like receptor gene family: Molecular characterization, genomic structure, physical mapping to the NK gene complex and expression analysis
79. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
80. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes
81. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein
82. Expression and cellular localization of the protein encoded by the 1C7 gene: A recently described component of the MHC
83. p46, a novel natural killer cell-specific surface molecule which mediates cell activation
84. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human natural killer cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells
85. Involvement of natural cytotoxicity receptors in human natural killer cell mediated lysis of neuroblastoma and glyoblastoma cell lines
86. 2B4 functions as a co-receptor in human NK cell activation
87. Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP
88. The CD2-subset of the Ig superfamily of cell surface molecules: Receptor-ligand pairs expressed by NK cells and other immune cells
89. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome
90. Biology of natural killer cell
91. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes
92. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in non-MHC restricted tumor cell lysis
93. Identification of NKp80 a novel triggering molecule expressed by human NK cells
94. Molecular clones of the p58 NK cell receptor reveal immunoglobulin related molecules with diversity in both the extra- and intracellular domains
95. Organization of the leukocyte cluster (LRC) on human chromosome 19q13.4
96. Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain
97. An activating immunoreceptor complex formed by NKG2D and DAP10
98. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in NK cells